What is Invesco Biotechnology & Genome ETF’s 1-month forecast?

Meyka AI projects PBE could trade near $76.39 in the next month, a move of -7.01% compared to today’s price.

What is Invesco Biotechnology & Genome ETF’s 1-year forecast?

By 2027, PBE is forecasted to reach $85.14, reflecting a 3.63% change from the current level.

What is Invesco Biotechnology & Genome ETF’s 5-year forecast?

The 2030 projection for PBE is $114.69, which represents a potential 39.61% change.

What is the 7-year outlook for Invesco Biotechnology & Genome ETF?

Over the next 7 years, PBE could trade around $127.35, showing a 55.02% move from today’s price.

Can Invesco Biotechnology & Genome ETF (PBE) reach $140 by 2030?

Meyka AI’s 2030 forecast places PBE at $114.69, making it unlikely to reach $140 by 2030 under current market conditions.

Invesco Biotechnology & Genome ETF

PBE•AMEX

Financial Services

Asset Management

$82.15

$0.10(0.12%)

U.S. Market opens in 0h 13m

Invesco Biotechnology & Genome ETF (PBE) Stock Forecast & Price Predictions

Get the latest Invesco Biotechnology & Genome ETF (PBE) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$76.39

Change↓ $-5.76 (-7.01%)

Quarterly Forecast

Predicted Price$85.69

Change↑ $3.54 (4.31%)

Yearly Forecast

Predicted Price$85.14

Change↑ $2.99 (3.63%)

3 Years Forecast

Predicted Price$99.91

Change↑ $17.76 (21.62%)

5 Years Forecast

Predicted Price$114.69

Change↑ $32.54 (39.61%)

7 Years Forecast

Predicted Price$127.35

Change↑ $45.20 (55.02%)

Invesco Biotechnology & Genome ETF Stock Forecast Summary

Invesco Biotechnology & Genome ETF (PBE) stock is currently priced at $82.15. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $76.39.

In the long term, PBE shows a bullish trend. The 2027 forecast points to $85.14 (3.63% change), while the 2031 forecast suggests $114.69 (39.61% change). Looking 7 years ahead, projections estimate the stock could trade near $127.35, a 55.02% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that Invesco Biotechnology & Genome ETF stock is expected to trade sideways over the coming years.

Investment Calculator

Estimate your potential returns on PBE using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of $1,000.00 in Invesco Biotechnology & Genome ETF and holding until May 26th, 2027, you could face a potential +$36.35 profit, reflecting a +3.6% ROI over the next 365 days. These projections help you better understand short-term market movements.

Investment Amount (USD)

HODL Until?

$Shares Bought

12.1729

@ $82.15/share

~Forecast Price

$85.14

1-year AI forecast

$Est. Portfolio Value

$1,036.35

+$36.35 profit

%ROI

+3.6%

return on investment

Invesco Biotechnology & Genome ETF yearly Price Forecast Chart

Explore the yearly forecast chart for PBE, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Invesco Biotechnology & Genome ETF over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for PBEForecasting details for PBE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Invesco Biotechnology & Genome ETF Stock Forecast 2026

The forecast for Invesco Biotechnology & Genome ETF (PBE) in 2026 suggests a price of $85.14, representing a 3.63% move from today’s price.

Average Target: $85.14

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Financial Services.
Macroeconomic factors such as interest rates and inflation.

Invesco Biotechnology & Genome ETF Stock Forecast 2030

By 2030, Meyka AI projects PBE could trade near $114.69, showing a potential 39.61% compared to current levels.

Average Target: $114.69

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward Invesco Biotechnology & Genome ETF.

Invesco Biotechnology & Genome ETF 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for PBE points to a price around $127.35, which is a projected 55.02% move from today’s level.

Average Target: $127.35

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
Invesco Biotechnology & Genome ETF’s ability to maintain market leadership.